Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by CMendozaon Sep 06, 2018 6:39pm
296 Views
Post# 28575787

$5-7/share before diageo makes the deal

$5-7/share before diageo makes the dealPot stocks don't move like your typical ole' stocks, I get it. I'm not a bear, but ACB looking real bearish right now. This month or next, if diageo makes a deal with ACB, SP will be $5-7 before they do, if ACB doesn't get any sort of partnership/deal, SP will go down to 2-$3. Will take a few years before SP hits more than $10 again because too much dilution for a $8B market cap company. Production capacity is the only thing they have going, everything else is still in the early stages.

ACB backpacks from other pot stocks which is sad. $9 TP from Eight Capital, 0.95/share value, highest P/E in the sector at 275, lowest GPE in the sector, lowest EP in the sector at 0.02. Better opportunities in the sector, I will come back to ACB next year. Will have some good days here and there but overall I think is going downhill even though it doesn't move like regular stocks.
Bullboard Posts